Samples, CoA, CFS and Supporting Certificates for Kenya Registration

Content verified as of 30 October 2026.

1. Key takeaways

• Supporting documents in a Kenya submission fall into four classes: samples, the certificate of analysis (CoA), the certificate of free sale (CFS) and regulatory approval in the country of origin. Each answers a different question and none substitutes for another.
• PPB’s power to take samples has an express basis: Rule 5(3) of LN 100 of 2022 provides that PPB may send samples for analysis and may consider assessment reports of other authorities.
• Within the 9 items for a Class A listing, item ③ is the PVoC pre-export verification certificate (issued jointly by a notified body and KEBS), which may be replaced by a certificate of conformity (CoC); item ⑤ is the CoA for materials of animal, human, microbial and/or recombinant origin and for production processes; item ⑥ requires the PPE CoA to be issued by a PPB-recognised laboratory; item ⑧ is regulatory approval in the country of origin.
• Establishment registration carries its own thresholds: Class B/C/D require a CFS from the country of manufacture or final assembly; Class C/D require pre-market approval or registration evidence from at least one IMDRF member regulatory authority, or confirmation of WHO prequalification.
• Fees are collected together with the documents: the Second Schedule is denominated in US dollars, with its collection basis including Rule 4(3)(l) of LN 100 of 2022, among others.

2. Legal basis

3. Expert insights

Insight 1: The four classes of supporting documents sit on three tracks; confusing them is the most common cause of rejection. Samples and the CoA belong to the product batch track, answering whether this batch is conforming; the CFS belongs to the market access track, answering whether the product may lawfully be sold in its country of manufacture; country-of-origin regulatory approval belongs to the marketing legality track, answering whether the product has been approved for market in some regulatory system. PVoC/CoC belongs to the customs clearance track. Kenya’s peculiarity is that it moves the PVoC, which is inherently a clearance document, forward into the Class A registration list, creating a structure of standards conformity before registration. Companies often treat the CFS and the country-of-origin approval as two names for one document, fill the same document into both fields, and are asked to correct both separately.

Insight 2: The forward shift of the PVoC means the registration and clearance timelines must be resequenced. Class A item ③ requires the PVoC pre-export verification certificate (issued jointly by a notified body and KEBS), with a CoC allowed as replacement; and at import the sequence is to obtain the CoC first, then apply through the KenTrade single window system to PPB for a batch import licence, with a separate licence required for each consignment. Here two readings diverge: whether the PVoC is handled once with long validity or consignment by consignment. GRZAN’s judgement: the PVoC/CoC submitted in the registration file proves conformity with standards, while the batch import licence at import is a separate procedure; the two run in parallel, and a company may not skip the batch import licence because a PVoC was already submitted (this process linkage is a practical estimate).

Insight 3: Lock the CFS issuer to the country of manufacture or final assembly. Establishment registration requires Class B/C/D to provide a CFS from the country of manufacture or final assembly. Where a product is designed in country A, assembled in country B and labelled in country C, which country issues it is a frequent point of dispute. A workable approach: prefer the country of final assembly; if its authority does not issue a CFS, have a manufacturing country with issuing capability issue it, with a one-page explanation of the relationship between the issuer and the actual place of production. At the same time, Class C/D must also meet the harder threshold of approval by at least one IMDRF member regulatory authority or WHO prequalification; the two requirements are cumulative, not alternatives.

Insight 4: Rule 4(3) binds documents and fees at the same entry point. The fees in the Second Schedule are denominated in US dollars, with the collection basis including Rule 4(3)(l), among others. The practical consequence: where documents are found incomplete, fee questions surface at the same time as document questions. The guidelines also state that the application fee is paid at submission and the evaluation fee when the application is accepted for evaluation, and that neither is refundable once the application is successfully submitted or once accepted, with withdrawal or refusal forfeiting both. Before deciding to withdraw and resubmit, calculate this sunk cost first.

4. Practical recommendations

1. File by the three tracks. GRZAN recommends a separate document package for the product batch track, the market access track and the marketing legality track, avoiding one document covering multiple fields.
2. Start the PVoC early. Begin the PVoC or obtain a CoC before the Class A submission and schedule it in parallel with registration.
3. Lock the CFS to the country of final assembly. Have the authority of the country of final assembly issue it; where it cannot, attach a one-page statement of the production relationship.
4. Prepare the original approval in parallel for Class C/D. Submit the IMDRF member regulatory authority approval or WHO prequalification cumulatively with the CFS, not as an alternative.
5. Reserve callable sample stock. PPB may take samples for analysis under Rule 5(3); prepare samples with packaging identical to the commercial version in advance.
6. Calculate the sunk cost before withdrawing. Neither the application fee nor the evaluation fee is refundable; assess the feasibility of correction before resubmission.

5. Verification checklist

• □ Are samples ready, in packaging identical to the commercial version, able to respond to a Rule 5(3) sampling request?
• □ Has the CoA been submitted where applicable, and for PPE issued by a PPB-recognised laboratory?
• □ Has a CFS from the country of manufacture or final assembly been obtained, with the issuing authority identified?
• □ Is the country-of-origin regulatory approval submitted separately and independently of the CFS?
• □ Has the PVoC pre-export verification certificate been obtained for Class A, or replaced by a CoC?
• □ Has Class C/D obtained approval from at least one IMDRF member regulatory authority or WHO prequalification?
• □ Can the validity periods of the four classes of supporting documents cover the review period (validity alignment is a practical estimate)?
• □ Has the non-refundability of the application and evaluation fees been confirmed and budgeted into the project?

Regulatory information verified as of 30 October 2026.

In African markets, the GRZAN regulatory team focuses on jurisdictions such as Kenya, Nigeria, South Africa and Egypt and maintains a verification mechanism built on primary regulatory sources. Every regulatory conclusion it issues rests solely on official gazettes, the original text of competent authority guidelines and public legal databases, with the verification date stated; any figure, timeline or amount that cannot be located in an official source is marked as a practical estimate and is never presented as presumption.

GRZAN services cover market access strategy and risk classification; preparation and review of registration dossiers in CSDT, STED and CTD formats; selection and management of local authorized representatives (LARs); quality management system and GMP/GSDP compliance support; post-market vigilance, change management and recall response; import clearance and PVoC coordination; regulatory intelligence subscriptions and corporate compliance ledgers.

For a Kenya market access plan for a specific product, contact the GRZAN regulatory team at info@grzanglobal.com.